目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Application
Market segments
Comparison by Application
Aesthetic - Market size and forecast 2020-2025
Medical - Market size and forecast 2020-2025
Market opportunity by Application

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Daewoong Bio Inc.
Evolus Inc
Galderma SA
Hugel Inc
Ipsen Pharma
Medytox Inc.
Merz Pharma GmbH and Co. KGaA
Revance Therapeutics Inc.
US WorldMeds

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Application - Market share 2020-2025 (%)
22: Comparison by Application
23: Aesthetic - Market size and forecast 2020-2025 ($ million)
24: Aesthetic - Year-over-year growth 2020-2025 (%)
25: Medical - Market size and forecast 2020-2025 ($ million)
26: Medical - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Application
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Daewoong Bio Inc. - Overview
48: Daewoong Bio Inc. - Product and service
49: Daewoong Bio Inc. - Key offerings
50: Daewoong Bio Inc. - Key customers
51: Daewoong Bio Inc. - Segment focus
52: Evolus Inc - Overview
53: Evolus Inc - Product and service
54: Evolus Inc - Key offerings
55: Evolus Inc - Key customers
56: Evolus Inc - Segment focus
57: Galderma SA - Overview
58: Galderma SA - Product and service
59: Galderma SA - Key offerings
60: Galderma SA - Key customers
61: Galderma SA - Segment focus
62: Hugel Inc - Overview
63: Hugel Inc - Product and service
64: Hugel Inc - Key offerings
65: Hugel Inc - Key customers
66: Hugel Inc - Segment focus
67: Ipsen Pharma - Overview
68: Ipsen Pharma - Business segments
69: Ipsen Pharma - Key offerings
70: Ipsen Pharma - Key customers
71: Ipsen Pharma - Segment focus
72: Medytox Inc. - Overview
73: Medytox Inc. - Business segments
74: Medytox Inc. - Key offerings
75: Medytox Inc. - Key customers
76: Medytox Inc. - Segment focus
77: Merz Pharma GmbH and Co. KGaA - Overview
78: Merz Pharma GmbH and Co. KGaA - Product and service
79: Merz Pharma GmbH and Co. KGaA - Key offerings
80: Merz Pharma GmbH and Co. KGaA - Key customers
81: Merz Pharma GmbH and Co. KGaA - Segment focus
82: Metabiologics, Inc. - Overview
83: Metabiologics, Inc. - Product and service
84: Metabiologics, Inc. - Key offerings
85: Metabiologics, Inc. - Key customers
86: Metabiologics, Inc. - Segment focus
87: Revance Therapeutics Inc. - Overview
88: Revance Therapeutics Inc. - Product and service
89: Revance Therapeutics Inc. - Key offerings
90: Revance Therapeutics Inc. - Key customers
91: Revance Therapeutics Inc. - Segment focus
92: US WorldMeds - Overview
93: US WorldMeds - Product and service
94: US WorldMeds - Key offerings
95: US WorldMeds - Key customers
96: US WorldMeds - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations